US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis
The U.S. Food and Drug Administration (FDA) has approved Jascayd (nerandomilast) tablets to treat idiopathic pulmonary fibrosis (IPF), a rare ...
The U.S. Food and Drug Administration (FDA) has approved Jascayd (nerandomilast) tablets to treat idiopathic pulmonary fibrosis (IPF), a rare ...
The U.S. Food and Drug Administration granted approval for Papzimeos (zopapogene imadenovec-drba), marking the introduction of a first-of-its-kind, non-replicating adenoviral ...
The U.S. Food and Drug Administration, FDA approves Brinsupri, Insmed's oral drug for a lung disease, the company announced. This ...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.